Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists

A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its development.

The document posted online on Wednesday by Kennedy’s Department of Health and Human Services (HHS) covers a handful of injectable peptides promoted within the wellness industry for building muscle, healing injuries and boosting energy.

Increase will add strain on healthcare system already struggling amid cuts by Trump administration, experts say

The number of people with dementia in the United States is projected to increase dramatically over the next 25 years, which will place increasing strain on a healthcare system already struggling to help them amid cuts by the Trump administration, experts say.

According to a new study in Jama Neurology, the annual incidence of new dementia cases globally will more than double, from 11.4m in 2023 to 24.7m in 2050. In the United States, the number of adults diagnosed with dementia each year will increase from 514,000 in 2020 to 1m by 2060, according to a Jama study published in 2024.